Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 19 of the 23 references it cites were found in a registry or an index.

The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends

Abstract

BACKGROUND Multiple myeloma accounted for 176 404 (14%) of 1 278 362 the incidence cases leukaemia, lymphoma, and multiple myeloma in 2020. Identifying its geographical distribution, risk factors, and epidemiological trends could help identify high-risk population groups. We aimed to examine the worldwide incidence, mortality, associated risk factors, and temporal trends of multiple myeloma by sex, age, and geographical region. METHODS The incidence and mortality of multiple myeloma were extracted from Global Cancer Observatory (2020), Cancer Incidence in Five Continents, WHO mortality database, Nordic Cancer Registries, and Surveillance, Epidemiology, and End Results Program (1980-2019). The WHO Global Health Observatory data repository was searched for the age-standardised prevalence of lifestyle and metabolic risk factors (2010). Associations with risk factors were examined by multivariable regression. The temporal trends were evaluated by average annual percentage change (AAPC) using joinpoint regression. FINDINGS The age-standardised rate (ASR) of multiple myeloma incidence was 1·78 (95% UI 1·69-1·87) per 100 000 people globally and mortality was 1·14 (95% UI 1·07-1·21) per 100 000 people globally in 2020. Increased incidence and mortality were associated with higher human development index, gross domestics product, prevalence of physical inactivity, overweight, obesity, and diabetes. Australia and New Zealand (ASR 4·86 [4·66-5·07]), northern America (4·74 [4·69-4·79]),…

Overview

Integrity signals

Registry

Crossref · 10.1016/s2352-3026(22)00165-x

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 23 references

Research works printed but not linked: 1

  1. Nwabuko, 2019, Risk factors versus causal inferences: the implications on multiple myeloma in developed versus developing countries, Onkologia i Radioterapia, 13, 84

Cited by

See all 229

Metadata

Authors
Huang, J., Chan, S. C., Lok, V., Zhang, L., Lucero-Prisno, D. E., Xu, W., Zheng, Z.-J., Elcarte, E., Withers, M., & Wong, M. C. S.
Affiliations
  • Chinese University of Hong Kong (HK)
  • Karolinska University Hospital (SE)
  • The University of Melbourne (AU)
  • Fudan University (CN)
  • Peking University (CN)
  • University of the Philippines Manila (PH)
  • University of Southern California (US)
Corresponding author
Wong, Martin C S
Venue
The Lancet Haematology
Publisher
Elsevier BV
Published
2022-09
Volume
9
Issue
9
Pages
e670-e677
ISSN
2352-3026 (ISSN-L)
OpenAlex
W4285498552
Cited by
229
References
23
Citations by year
2026: 51 · 2025: 84 · 2024: 57 · 2023: 32 · 2022: 4
FWCI
32.18
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet Haematology (publishedVersion)
  • PubMed (publishedVersion)
Funders
World Health Organization
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Epidemiology › Multiple and Secondary Primary Cancers
Keywords
multiple myeloma, incidence, mortality, risk factors, temporal trends, geographic distribution, physical inactivity, obesity, diabetes mellitus, Human Development Index, economic development, sex differences, age-standardized rates, global cancer burden, cancer registry data, lifestyle risk factors, metabolic risk factors, cancer prevention policy, health equity, cancer screening and early detection, cancer survivorship
MeSH terms
Female, Humans, Male, Multiple Myeloma, Registries, Risk Factors, Global Health, Incidence, Cost of Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. https://app.cochat.ai/papers/10.1016/s2352-3026(22)00165-x
The paper
Huang, J., Chan, S. C., Lok, V., Zhang, L., Lucero-Prisno, D. E., Xu, W., Zheng, Z.-J., Elcarte, E., Withers, M., & Wong, M. C. S. (2022). The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. The Lancet Haematology. https://doi.org/10.1016/s2352-3026(22)00165-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.